Beth E. Mooney - 01 Feb 2023 Form 4 Insider Report for Accenture plc (ACN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Feb 2023, 15:52:21 UTC
Prior SEC filing
02 Feb 2023
Next SEC filing
17 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Danika Haueisen, Attorney-In-Fact for Beth E. Mooney

Key filing fact

Beth E. Mooney filed Form 4 for Accenture plc (ACN) on 02 Feb 2023.

Key facts

  • This page summarizes Beth E. Mooney's Form 4 filing for Accenture plc (ACN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Feb 2023, 15:52.

Change

  • Previous filing in this sequence was filed on 02 Feb 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACN transaction

Class A ordinary shares

Award

Transaction value
$0
Shares
+855
Change %
+75%
Price
$0.000000
Shares after
1,994
Date
01 Feb 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a grant of restricted share units awarded under the Accenture plc Amended and Restated 2010 Share Incentive Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .